2020
DOI: 10.1111/jphd.12357
|View full text |Cite
|
Sign up to set email alerts
|

Predicted prevalence of oral human papillomavirus (HPV) by periodontitis status and HPV vaccination status

Abstract: Objectives The purpose of the present study was to examine differences in oral human papillomavirus (HPV) prevalence among adults based on HPV vaccination status and periodontitis status. Methods Data from 2011 to 2012 and 2013 to2014 National Health and Nutrition Examination Surveys (n = 822) were retrieved in order to predict the prevalence of oral HPV in 24 separate demographic groups (age by sex by race) based on the following characteristics: HPV vaccination status and periodontitis status. A multiple log… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2021
2021
2024
2024

Publication Types

Select...
3

Relationship

0
3

Authors

Journals

citations
Cited by 3 publications
(1 citation statement)
references
References 27 publications
(66 reference statements)
0
1
0
Order By: Relevance
“…HPV vaccines became first available in 2006. Gardasil 9, a nonavalent HPV vaccine became available in 2014 and was recommended for use by the Advisory Committee on Immunization Practices in 2015 [ 14 , 15 ]. Routine HPV vaccination is recommended to start or complete by age 11–12, and the first dose can be administered as early as age 9.…”
Section: Introductionmentioning
confidence: 99%
“…HPV vaccines became first available in 2006. Gardasil 9, a nonavalent HPV vaccine became available in 2014 and was recommended for use by the Advisory Committee on Immunization Practices in 2015 [ 14 , 15 ]. Routine HPV vaccination is recommended to start or complete by age 11–12, and the first dose can be administered as early as age 9.…”
Section: Introductionmentioning
confidence: 99%